![Andrew Goldberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 M $ al 30/06/2026
Andrew D.
Goldberg is Chief Executive Officer & Director at Achieve Life Sciences, Inc. since 2026.
Dr. Goldberg is Independent Director at Tarsus Pharmaceuticals, Inc. since 2020.
Former roles include Chairman at Swift Health Systems, Inc., Director at Ossium Health, Inc., and Vice President & Market Strategist at JPMorgan Investment Management, Inc. from 2002 to 2011.
Education includes undergraduate studies at Bryant University and a doctorate from George Washington University School of Medicine & Health.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 25/06/2026 | 19.654 ( 0,05 % ) | 1 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TARSUS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 01/08/2020 |
| ACHIEVE LIFE SCIENCES, INC. | Director Ejecutivo | 18/04/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
Swift Health Systems, Inc.
 Swift Health Systems, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company which develops invisible orthodontic solutions | Presidente | - |
Ossium Health, Inc.
 Ossium Health, Inc. BiotechnologyHealth Technology Develops first-of-its-kind solution for processing, banking and deploying bone marrow derived cell therapies | Director/Miembro de la Junta | - |
JPMorgan Investment Management, Inc.
 JPMorgan Investment Management, Inc. Investment ManagersFinance JPMIM seeks to generate positive excess return through both a bottom-up approach emphasizing security selection and a top-down approach focusing on macro investment themes and trends to aid in determining sector weightings, currency, and yield curve weighting where appropriate. The firm offers a broad range of US, non-US and global investment management products and provides different strategies that span the full spectrum of asset classes including equity, fixed-income, cash liquidity, currency, real estate, hedge funds and private equity. | Estratega de mercado | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
JPMorgan Investment Management, Inc.
JPMorgan Investment Management, Inc. Investment ManagersFinance JPMIM seeks to generate positive excess return through both a bottom-up approach emphasizing security selection and a top-down approach focusing on macro investment themes and trends to aid in determining sector weightings, currency, and yield curve weighting where appropriate. The firm offers a broad range of US, non-US and global investment management products and provides different strategies that span the full spectrum of asset classes including equity, fixed-income, cash liquidity, currency, real estate, hedge funds and private equity. | Finance |
Bryant University
 Bryant University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swift Health Systems, Inc.
Swift Health Systems, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company which develops invisible orthodontic solutions | Health Technology |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
George Washington University School of Medicine & Health
 George Washington University School of Medicine & Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ossium Health, Inc.
Ossium Health, Inc. BiotechnologyHealth Technology Develops first-of-its-kind solution for processing, banking and deploying bone marrow derived cell therapies | Health Technology |
Tarsus Pharmaceuticals, Inc.
 Tarsus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapeutic drugs for blepharitis | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
